Position in FTRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,799,978
+$3,532,103 QoQ
Shares Held
509,552
+593.3% QoQ
Ownership
0.539%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Derivatives in FTRE
reported options exposure · as of Mar 31, 2026CallValue
$291,078
CallShares
30,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITADEL ADVISORS LLC holds $5,783,571,443 across 373 Biotechnology names. FTRE ranks #126 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
2,182,571 | $356,894,009 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
1,032,298 | $306,561,536 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
4,512,634 | $254,918,694 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,259,444 | $238,097,887 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
453,843 | $237,573,195 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
3,173,940 | $235,696,783 | |
| 7 | TERN |
Terns Pharmaceuticals, Inc.
|
3,218,810 | $169,695,662 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
1,551,900 | $163,570,260 |
All Filings in FTRE
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $291,078 | 30,900 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $4,799,978 | 509,552 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,267,875 | 73,500 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $211,342 | 25,100 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $321,644 | 38,200 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $5,131,248 | 609,412 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $735,852 | 148,958 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $217,360 | 44,000 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $164,590 | 21,800 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $8,023,935 | 1,062,773 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $98,150 | 13,000 | Put | Defined | 2025-05-15 | |
| 2024-12-31 | $829,925 | 44,500 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $837,385 | 44,900 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $3,271,470 | 175,414 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,252,000 | 62,600 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $448,000 | 22,400 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $6,297,180 | 314,859 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $371,106 | 15,900 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $742,212 | 31,800 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $5,811,565 | 248,996 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $58,869,966 | 1,466,616 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $915,192 | 22,800 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $2,685,366 | 66,900 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $663,100 | 19,000 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $74,736,395 | 2,141,444 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $1,444,860 | 41,400 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $3,224,952 | 112,800 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $1,978,428 | 69,200 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $63,676,305 | 2,227,223 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||